ILLUMINA INC (ILMN) Stock Fundamental Analysis

NASDAQ:ILMN • US4523271090

117.67 USD
-2.33 (-1.94%)
At close: Feb 20, 2026
117.67 USD
0 (0%)
After Hours: 2/20/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, ILMN scores 6 out of 10 in our fundamental rating. ILMN was compared to 58 industry peers in the Life Sciences Tools & Services industry. While ILMN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ILMN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • ILMN had positive earnings in the past year.
  • In the past year ILMN had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ILMN reported negative net income in multiple years.
  • In the past 5 years ILMN always reported a positive cash flow from operatings.
ILMN Yearly Net Income VS EBIT VS OCF VS FCFILMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B -4B

1.2 Ratios

  • The Return On Assets of ILMN (11.38%) is better than 91.38% of its industry peers.
  • ILMN has a better Return On Equity (29.53%) than 96.55% of its industry peers.
  • ILMN has a better Return On Invested Capital (16.25%) than 93.10% of its industry peers.
Industry RankSector Rank
ROA 11.38%
ROE 29.53%
ROIC 16.25%
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
ILMN Yearly ROA, ROE, ROICILMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60

1.3 Margins

  • The Profit Margin of ILMN (16.39%) is better than 89.66% of its industry peers.
  • ILMN's Profit Margin has been stable in the last couple of years.
  • ILMN has a Operating Margin of 20.41%. This is amongst the best in the industry. ILMN outperforms 87.93% of its industry peers.
  • ILMN's Operating Margin has improved in the last couple of years.
  • The Gross Margin of ILMN (66.74%) is better than 89.66% of its industry peers.
  • In the last couple of years the Gross Margin of ILMN has remained more or less at the same level.
Industry RankSector Rank
OM 20.41%
PM (TTM) 16.39%
GM 66.74%
OM growth 3Y38.39%
OM growth 5Y2.71%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
ILMN Yearly Profit, Operating, Gross MarginsILMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ILMN is creating some value.
  • Compared to 1 year ago, ILMN has less shares outstanding
  • Compared to 5 years ago, ILMN has more shares outstanding
  • The debt/assets ratio for ILMN has been reduced compared to a year ago.
ILMN Yearly Shares OutstandingILMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ILMN Yearly Total Debt VS Total AssetsILMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 4.06 indicates that ILMN is not in any danger for bankruptcy at the moment.
  • ILMN has a Altman-Z score of 4.06. This is amongst the best in the industry. ILMN outperforms 81.03% of its industry peers.
  • ILMN has a debt to FCF ratio of 1.99. This is a very positive value and a sign of high solvency as it would only need 1.99 years to pay back of all of its debts.
  • The Debt to FCF ratio of ILMN (1.99) is better than 87.93% of its industry peers.
  • ILMN has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.42, ILMN perfoms like the industry average, outperforming 41.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.99
Altman-Z 4.06
ROIC/WACC1.52
WACC10.72%
ILMN Yearly LT Debt VS Equity VS FCFILMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.43 indicates that ILMN should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.43, ILMN is doing worse than 75.86% of the companies in the same industry.
  • ILMN has a Quick Ratio of 1.12. This is a normal value and indicates that ILMN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.12, ILMN is not doing good in the industry: 74.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.12
ILMN Yearly Current Assets VS Current LiabilitesILMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • ILMN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.96%, which is quite impressive.
  • Measured over the past 5 years, ILMN shows a small growth in Earnings Per Share. The EPS has been growing by 1.51% on average per year.
  • ILMN shows a decrease in Revenue. In the last year, the revenue decreased by -0.66%.
  • Measured over the past years, ILMN shows a small growth in Revenue. The Revenue has been growing by 6.04% on average per year.
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%

3.2 Future

  • Based on estimates for the next years, ILMN will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.14% on average per year.
  • The Revenue is expected to grow by 6.07% on average over the next years.
EPS Next Y6.75%
EPS Next 2Y10.5%
EPS Next 3Y9.64%
EPS Next 5Y12.14%
Revenue Next Year2.81%
Revenue Next 2Y4.54%
Revenue Next 3Y4.65%
Revenue Next 5Y6.07%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ILMN Yearly Revenue VS EstimatesILMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
ILMN Yearly EPS VS EstimatesILMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 24.26, ILMN is valued on the expensive side.
  • ILMN's Price/Earnings ratio is a bit cheaper when compared to the industry. ILMN is cheaper than 74.14% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.99. ILMN is around the same levels.
  • Based on the Price/Forward Earnings ratio of 22.73, the valuation of ILMN can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, ILMN is valued a bit cheaper than the industry average as 74.14% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. ILMN is around the same levels.
Industry RankSector Rank
PE 24.26
Fwd PE 22.73
ILMN Price Earnings VS Forward Price EarningsILMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ILMN is valued cheaply inside the industry as 82.76% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, ILMN is valued cheaply inside the industry as 87.93% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.98
EV/EBITDA 16.37
ILMN Per share dataILMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of ILMN may justify a higher PE ratio.
PEG (NY)3.6
PEG (5Y)16.07
EPS Next 2Y10.5%
EPS Next 3Y9.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ILMN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ILLUMINA INC

NASDAQ:ILMN (2/20/2026, 8:00:01 PM)

After market: 117.67 0 (0%)

117.67

-2.33 (-1.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners104.7%
Inst Owner Change-1.36%
Ins Owners0.17%
Ins Owner Change-0.2%
Market Cap17.98B
Revenue(TTM)4.34B
Net Income(TTM)703.00M
Analysts72.31
Price Target135.91 (15.5%)
Short Float %5.44%
Short Ratio4.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.9%
Min EPS beat(2)12.52%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)5.34%
Min EPS beat(4)-7.76%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)97.15%
EPS beat(12)10
Avg EPS beat(12)231.96%
EPS beat(16)13
Avg EPS beat(16)178.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.78%
PT rev (1m)7.63%
PT rev (3m)19.07%
EPS NQ rev (1m)1.31%
EPS NQ rev (3m)0.6%
EPS NY rev (1m)1.01%
EPS NY rev (3m)2.37%
Revenue NQ rev (1m)0.53%
Revenue NQ rev (3m)0.09%
Revenue NY rev (1m)0.47%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 24.26
Fwd PE 22.73
P/S 4.19
P/FCF 17.98
P/OCF 16.02
P/B 7.55
P/tB 17.24
EV/EBITDA 16.37
EPS(TTM)4.85
EY4.12%
EPS(NY)5.18
Fwd EY4.4%
FCF(TTM)6.54
FCFY5.56%
OCF(TTM)7.34
OCFY6.24%
SpS28.06
BVpS15.58
TBVpS6.83
PEG (NY)3.6
PEG (5Y)16.07
Graham Number41.24
Profitability
Industry RankSector Rank
ROA 11.38%
ROE 29.53%
ROCE 20.76%
ROIC 16.25%
ROICexc 23.32%
ROICexgc 42.83%
OM 20.41%
PM (TTM) 16.39%
GM 66.74%
FCFM 23.32%
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y3.11%
ROICexgc growth 5Y5.93%
ROICexc growth 3Y76.04%
ROICexc growth 5Y5.12%
OM growth 3Y38.39%
OM growth 5Y2.71%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.99
Debt/EBITDA 0.86
Cap/Depr 44.36%
Cap/Sales 2.85%
Interest Coverage 250
Cash Conversion 97.57%
Profit Quality 142.25%
Current Ratio 1.43
Quick Ratio 1.12
Altman-Z 4.06
F-Score7
WACC10.72%
ROIC/WACC1.52
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
EPS Next Y6.75%
EPS Next 2Y10.5%
EPS Next 3Y9.64%
EPS Next 5Y12.14%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%
Revenue Next Year2.81%
Revenue Next 2Y4.54%
Revenue Next 3Y4.65%
Revenue Next 5Y6.07%
EBIT growth 1Y154.36%
EBIT growth 3Y35.92%
EBIT growth 5Y8.92%
EBIT Next Year30.31%
EBIT Next 3Y19.36%
EBIT Next 5Y16.64%
FCF growth 1Y82.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y60.98%
OCF growth 3YN/A
OCF growth 5YN/A

ILLUMINA INC / ILMN FAQ

Can you provide the ChartMill fundamental rating for ILLUMINA INC?

ChartMill assigns a fundamental rating of 6 / 10 to ILMN.


Can you provide the valuation status for ILLUMINA INC?

ChartMill assigns a valuation rating of 5 / 10 to ILLUMINA INC (ILMN). This can be considered as Fairly Valued.


How profitable is ILLUMINA INC (ILMN) stock?

ILLUMINA INC (ILMN) has a profitability rating of 7 / 10.


What is the financial health of ILLUMINA INC (ILMN) stock?

The financial health rating of ILLUMINA INC (ILMN) is 6 / 10.


What is the expected EPS growth for ILLUMINA INC (ILMN) stock?

The Earnings per Share (EPS) of ILLUMINA INC (ILMN) is expected to grow by 6.75% in the next year.